findmyKOL

Samuel Bailin

Basic profile

Vanderbilt University

ORCIDNPI
RegionNashville, TN · SoutheastSpecialtyInfectious DiseaseFocusInfectious Disease
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding2023–2026Why? →

Samuel Bailin is an Infectious Disease physician affiliated with Vanderbilt University. OpenAlex indexes 70 publications with 1,139 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
70publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,139citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 2023–2026

Federally funded research awards.

View funding

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    46.1%
    Protease Inhibitor15.5%
    Prezcobix50%Ritonavir23%Prezista17%Atazanavir Sulfate10%
    Part D<11 patients
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor12%
    Triumeq46%Abacavir-Lamivudine24%Descovy16%Emtricitabine-Tenofovir Disop15%
    Part D<11 patients

    + 5 more classes in this area

  • Cardiovascular

    29.7%
    Statin13%
    Atorvastatin Calcium100%
    Part D18 patients
    Angiotensin receptor blocker (ARB)4.1%
    Losartan Potassium57%Telmisartan43%
    Part D<11 patients

    + 6 more classes in this area

  • Metabolism & gastrointestinal

    13.5%
    Proton pump inhibitor5.9%
    Omeprazole100%
    Part D<11 patients
    Biguanide (metformin)2.8%
    Metformin Hcl100%
    Part D<11 patients

    + 3 more classes in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20232026 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”